The Board of Directors in their meeting held today have approved the Audited Standalone Financial Results for the half year and year ended on 31st March, 2025. Pursuant to Regulation ....
Price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
On the reaction day the stock moved 1.0 pts more than Nifty Microcap 250 and 1.4 pts more than its Specialty Chemicals peers, over the same two closes: a difference in percentage points, not a measure of what the filing did.
Minute windows have no benchmark: there is no intraday index history to compare against.
Technichem Organics' Board approved audited FY25 results on 28 May 2025 with an unmodified audit opinion. Revenue from operations grew a strong 22.4% year-on-year to Rs. 5,678.23 lakhs (from Rs. 4,639.11 lakhs), but profit after tax slipped about 8% to Rs. 402.88 lakhs (from Rs. 438.20 lakhs) as costs rose faster than sales. EBITDA margins compressed sharply from around 21% to 14%, with material costs and other expenses eating into profitability. Despite higher revenue, operating cash flow turned sharply negative at Rs. (701.55) lakhs versus Rs. 201.66 lakhs last year, driven by a jump in inventories and receivables. The company, which got listed on BSE in January 2025 after a Rs. 25.24 crore IPO, has utilized IPO proceeds for loan repayment (Rs. 10.24 cr) and general corporate purposes, while Rs. 7.04 cr earmarked for a new plant remains unutilized.
Mixed picture for shareholders: strong top-line growth is offset by shrinking margins and a negative operating cash flow, which may pressure the stock in the short term. Dilution from the recent IPO and bonus issue also means EPS dropped to Rs. 3.03 versus Rs. 17.21 prior, though that is largely a share-count effect rather than underlying weakness.